-

Sol-Millennium Receives FDA Clearance for Sol-Guard Safety Pull Button Blood Collection Set

CHICAGO--(BUSINESS WIRE)--Sol-Millennium Inc., a medical device company and innovator in medication delivery and specimen collection, announced it has received a new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its proprietary Sol-Guard® Safety Pull Button Blood Collection Set, the newest safety device in the company's rapidly expanding blood collection portfolio. The Sol-Guard® Safety Pull Button Blood Collection Set features spring-activated needle retraction technology, designed to minimize the risk of accidental needlesticks and exposure to blood-borne pathogens. The company believes this device will be instrumental in its ongoing efforts to improve the blood collection experience for both clinicians and the patients entrusted in their care.

“We are extremely pleased to have received FDA clearance of our latest addition to our blood collection product portfolio. This has been a monumental year for Sol-Millennium, as we have been recognized internationally with awards from both Red Dot and iF Design organizations for the product’s innovative design,” said CEO Liang Lin.

“Sharps-related injuries continue to impact our already stressed healthcare community. The launch of the Sol-Guard® Safety Pull Button Blood Collection Set offers healthcare professionals another layer of protection and safety. Our customers desire multiple product choices so that they can provide their staff the right product to best meet their clinical needs at an affordable price point,” said Maroun Abouzeid, Sr Global Director - Diagnostics Business Unit.

To learn more information, click here.

About Red Dot Design Award:

For more than 60 years, the distinction “Red Dot” has become established internationally as one of the most sought-after seals of quality for good design. In order to appraise the diversity in the field of design in a professional manner, the award breaks down into three disciplines: Product Design, Brands & Communication Design, and Design Concept.

About iF Design Award:

Since 1953, the iF DESIGN AWARD has long been a symbol for excellent form, for aesthetic quality, and for user-focused, ergonomic and efficient design in all disciplines, by companies around the world. Over 11,000 entries from 57 countries were submitted to the iF DESIGN AWARD in 2022!

About Sol-Millennium

Sol-Millennium is a Chicago-based global supplier that has been manufacturing products for notable brands in the US market since 2009. In addition to needles and syringes, Sol M’s product portfolio includes winged safety blood collection sets, safety multi-sample needles and a variety of other diagnostics, diabetes, and PPE-related products. During the pandemic, Sol M sold over 2 billion of their market leading low dead space syringes to aid in the worldwide vaccination campaign.

Contacts

Colin Phelan
Sr. Global Product Manager
Blood Collection Devices
Sol-Millennium Medical Inc.
cphelan@solm.com
www.solm.com

Sol-Millennium Inc.


Release Versions

Contacts

Colin Phelan
Sr. Global Product Manager
Blood Collection Devices
Sol-Millennium Medical Inc.
cphelan@solm.com
www.solm.com

Social Media Profiles
More News From Sol-Millennium Inc.

Sol-Millennium® Celebrates Positive Feedback on Needle-Free Insulin Injection Device in Canada

CHICAGO--(BUSINESS WIRE)--Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin administration, receiving widespread praise in Canada. Designed to improve the lives of millions of people with diabetes, this breakthrough technology eliminates the discomfort and anxiety often associated with traditional needle-based injections. The device, InsuJet™, employs advanced jet injection technology to deliver precise...

Sol-Millennium® Launches Revolutionary Needle-Free Injection Device for Insulin Administration in Canada

CHICAGO--(BUSINESS WIRE)--Sol-Millennium® Medical Group, manufacturer of medical devices, including syringes for medication delivery and testing, is proud to announce the launch of InsuJet™ Needle-free Device, designed specifically for the administration of insulin for diabetic patients. This innovative technology promises to enhance the quality of life for millions of individuals living with diabetes by eliminating the discomfort associated with traditional needle-based injections. InsuJet™ Ne...

Sol-Millennium Responds to FDA’s Warning Letter and Safety Communication

CHICAGO--(BUSINESS WIRE)--Sol-Millennium responds to FDA's Warning Letter and Safety Communication....
Back to Newsroom